PSNL (Personalis, Inc.) Earnings per share growth rate in current year

PSNL (Personalis, Inc.) - company brandmark

Personalis, Inc. is realizing the premium value of its high-precision genomic tests, as evidenced by the history of annual earnings per share changes. The current status of the parameter is determined by -22.30. Business stability is supported by full humanitarian immunity to sanctions, although operational processes rely on external cloud IT services for data array storage.

Personalis, Inc. - PSNL Earnings growth in current year (period 07/04/2022 - 11/15/2026)

Analytical breakdowns and data insights for company Personalis Inc (PSNL)

- stock price and consensus target price:
Price Performance Chart Personalis Corp|PSNL - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Personalis, Inc.|PSNL - Total Company Value
- balance sheet equity data:
Share Book Value Personalis|PSNL - Book Capitalization|Market-to-Book Ratio personalis.com|PSNL - Aggregate Company Assets
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Personalis, Inc.|PSNL - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Personalis Inc|PSNL - Company Debts|Debts to Book Value Personalis, Inc.|PSNL - Company Long-Term Debt|Company Short-Term Indebtedness Personalis|Quick Ratio personalis.com
- financial results and valuation multiples details:
PSNL - Company Net Income|Expected Profit Personalis, Inc.|PSNL - P/E Multiple|Market Cap to Projected Earnings personalis.com|PSNL - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Personalis Inc|PSNL - Operating profit before deduction of amortization|Earnings per share for the trailing year Personalis|PSNL - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months personalis.com|PSNL - Earnings per share growth in current year|Projected earnings per share growth rate for next year Personalis, Inc.
- sales volume and revenue information:
PSNL - Revenue and Sales Volume|Company Future Sales Volume Personalis, Inc.|PSNL - Market Cap to Revenue|Market Cap to Expected Sales Ratio Personalis, Inc.|PSNL - Sales Growth YoY (Last Twelve Months)
Basic company analysis:PSNL Personalis Genomics
Manufactured products of Personalis

The efficiency of implementing AI-driven DNA analysis platforms and the performance of elite bioinformaticians at Personalis, Inc. (PSNL) are directly reflected in the annual earnings per share (EPS) growth indicator. This metric measures the percentage change in EPS relative to the previous year, neutralizing quarterly gaps and revealing the true balance of power; steady growth here confirms the fundamental resilience of the business and the high quality of the company's assets.

Main competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|Erasca Oncology - Earnings growth in current year|DCTH: Earnings per share growth in current year|YMAB: Earnings growth in current year|Aura Bio (AURA) - Earnings growth in current year|CADL (Candel Therapeutics Inc.) - Earnings growth in current year|ARAY: Earnings per share increase in current year|Net earnings per share growth this year SLS (SELLAS Life Sciences Group, Inc.)|Net earnings per one share growth for the current year ACTU|Citius Oncology - Net earnings per share growth this year|Earnings per share increase in current year HURA|TARA: Net earnings per share growth this year|Earnings per share growth rate in current year Fate Pharma|Aadi Bioscience Inc (WHWK) - Earnings per share growth in current year|Earnings per share growth rate in current year TScan (TCRX)|Net earnings per share growth this year CSBR|xbiotech.com (XBIT) - Expected net earnings per share growth this year|Earnings per share growth in current year cel-sci.com (CVM)|OSTX - Earnings per share growth rate in current year|Radiopharm Theranostics - Net earnings per share growth this year|Earnings per share increase in current year ARTV|ANL - Earnings per share growth in current year|VERU - Earnings growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma